22 May 2013
Keywords: vectura, ed, drug, impresses, 2nd, ph, iib
Article | 30 April 2007
Vectura, a UK drugmaker focused on the development of inhaled drug formulations for the treatment of both lung diseases and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 April 2007
© 2013 thepharmaletter.com